Cresco Labs (CRLBF) Operating Expenses (2020 - 2026)
Cresco Labs' (CRLBF) quarterly Operating Expenses came in at $64.3 million in Q1 2026, down 1.18% YoY from $65.0 million in Q1 2025, and down 59.54% on a QoQ basis from $158.9 million in Q4 2025.
Cresco Labs (CRLBF) Operating Expenses (2020 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Operating Expenses data on file, last reported at $64.3 million in Q1 2026.
- Quarterly Operating Expenses fell 1.18% year-over-year to $64.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $351.8 million (up 35.74% YoY) and the FY2025 annual result came in at $352.6 million, up 37.09% from the prior year.
- Operating Expenses retreated to $64.3 million in Q1 2026, from $158.9 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $231.2 million in Q4 2022 to a low of $61.5 million in Q3 2025.
- A 5-year average of $95.0 million and a median of $69.0 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses plunged 71.98% — and 2025, when it surged 145.85%.
- Tracing CRLBF's Operating Expenses over 5 years: stood at $231.2 million in 2022, then plunged by 70.13% to $69.0 million in 2023, then slipped by 6.41% to $64.6 million in 2024, then surged by 145.85% to $158.9 million in 2025, then slumped by 59.54% to $64.3 million in 2026.
- The last three Operating Expenses figures came in at $64.3 million (Q1 2026), $158.9 million (Q4 2025), and $61.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Cresco Labs | 291.27 Mn | 227.16 Mn | 86.95 Mn | 73.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.28 Mn |
| Dec 31, 2025 | 158.87 Mn |
| Sep 30, 2025 | 61.53 Mn |
| Jun 30, 2025 | 67.12 Mn |
| Mar 31, 2025 | 65.04 Mn |
| Dec 31, 2024 | 64.62 Mn |
| Sep 30, 2024 | 67.10 Mn |
| Jun 30, 2024 | 62.40 Mn |
| Mar 31, 2024 | 63.05 Mn |
| Dec 31, 2023 | 69.05 Mn |
| Sep 30, 2023 | 201.40 Mn |
| Jun 30, 2023 | 97.45 Mn |
| Mar 31, 2023 | 82.29 Mn |
| Dec 31, 2022 | 231.18 Mn |
| Sep 30, 2022 | 82.87 Mn |
| Jun 30, 2022 | 90.15 Mn |
| Mar 31, 2022 | 87.11 Mn |
| Dec 31, 2021 | 94.47 Mn |
| Sep 30, 2021 | 295.79 Mn |
| Jun 30, 2021 | 86.11 Mn |